New drug approvals plummet in 2016

被引：0

|

作者：

Mullin, Rick

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2017年 / 95卷 / 02期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：10 / 10

页数：1

相关论文

共 50 条

[21] Endpoints for New Drug Approvals in AML
Estey, Elihu
ANNALS OF HEMATOLOGY, 2017, 96 : S21 - S23
[22] THE TIMELINESS OF NEW DRUG APPROVALS IN CANADA
RAWSON, NSB
INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1995, 25 (01): : 153 - 165
[23] FDA Guidance and New Drug Approvals
Walker, Scot
HOSPITAL PHARMACY, 2018, 53 (06) : 360 - 362
[24] New Drug Approvals for Prostate Cancer
Tannock, Ian F.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (05) : 245 - 246
[25] FINDING INFORMATION ON NEW DRUG APPROVALS
SNOW, B
DATABASE, 1992, 15 (05): : 83 - 87
[26] Bureaucrat is new head of drug approvals
Eggertson, L
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) : 863 - 863
[27] Drug approvals in India (vol 4, pg 18, 2016)
Jain, M.
Jani, R. H.
LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (02): : E2 - E2
[28] ITALIAN DRUG SALES PLUMMET
KEATES, T
LANCET, 1994, 343 (8899): : 725 - 725
[29] 2016 in review: FDA approvals of new molecular entities
Griesenauer, Rebekah H.
Kinch, Michael S.
DRUG DISCOVERY TODAY, 2017, 22 (11) : 1593 - 1597
[30] THE TIMELINESS OF NEW DRUG APPROVALS IN CANADA - A REJOINDER
LEXCHIN, J
INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1995, 25 (01): : 167 - 171

← 1 2 3 4 5 →